Private Capital Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
AAIS
Private Capital Advisors's EW Position: Q2 2026 in Review
Private Capital Advisors held its Edwards Lifesciences (EW) position steady in Q2 2026 at 13,200 shares worth $1.19M. The position accounts for 0.1% of the portfolio, ranked #37.
Private Capital Advisors first reported a position in EW in Q3 2017 and has held it in 19 quarters since. The position peaked at $5.41M in Q1 2022. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Private Capital Advisors held 13,200 shares of Edwards Lifesciences worth $1.19M as of Q2 2026.
- Private Capital Advisors left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.1% of Private Capital Advisors's portfolio in Q2 2026, its #37 holding.
- Private Capital Advisors first reported a position in Edwards Lifesciences in Q3 2017 and has held it in 19 quarters since.
- Private Capital Advisors's Edwards Lifesciences position peaked at $5.41M in Q1 2022.
- 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Private Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.